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Abstract 
Phenytoin as an anti-seizure medication, is useful for the prevention of tonic-clonic seizures and focal 
seizures. In this study we focused on the probable effects of Phenytoin drug on gene expression profile 
of liver related to lipid metabolism balance in mouse as a model. In this study, a group including 7 male 
mice of BALB/c were treated with phenytoin 3–5 mg/kg/day orally and a group including 7 male mice 
of BALB/c were took standard food. Liver tissue samples were isolated. Total RNA was extracted and 
cDNA was synthesized. Expression of Akt1, Leptin, Adipoq and GLUT4 genes was measured using Real-
time RT-PCR method. Results showed an increase about 15 and 3 fold changes in Akt1 (P <0.001) and 
Adipoq (P <0.001) gene expression respectively in treatment group compare to control mice. Also, we 
detected decreasing in Leptin and GLUT4 genes expression in the mice treated with phenytoin drug. 
Several studies indicated that phenytoin can promote hyperglycemia in human and animal. We 
proposed here that this effects may resulted from an interference between the phenytoin drug and gene 
expression profile in liver. Decreasing of leptin level here may be a result of glucose level elevation in 
blood that can induce a satiety situation result in decrease of leptin production. It may that Akt1 gene 
expression is increased to compensate the low level of GLUT4 protein. We concluded that phenytoin is 
a relatively high-risk antiepileptic drug for obesity and metabolic syndrome, but more studies are 
needed. 
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1. Introduction  
Side effects of drugs is a prevalent problem 
between the challenges of clinical medicine. Many of 
medications are vital to treat diseases, but sometimes 
they have serious side effects [1]. Phenytoin is one of 
the most effective drugs in treatment and prevention 
of acute repetitive seizures [2]. Phenytoin is believed to 
control the seizures by its effects on the voltage-gated 
sodium channels. This reduces the activity of brain 
seizure centers by stabilizing the nerve cell membranes 
                                                          
*Corresponding author:  
Ali Mohammad Ahadi, Ph.D 
Department of Genetics, Faculty of Science,  
Shahrekord University, Shahrekord, Iran  




Received: April, 07, 2021 
Accepted: May, 15, 2021 
[3]. This drug blocks the inflow of sodium ions through 
the membranes of the neurons, thereby limiting 
neurological impulses [4]. The most common side 
effects of phenytoin include headache, nausea, fever 
and enlargement of the gums. Phenytoin consumption 
may be lead to serious side effects include sleepiness, 
liver problems and low blood pressure [5].  
There are several investigations regarding the 
effects of phenytoin on the metabolism. Studies have 
shown that phenytoin induce hyperglycemia and 
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insulin resistance in experimental animal models and 
human fetus [6, 7]. High levels of blood sugar can lead 
to complications such as diabetes and metabolic 
syndrome. Diabetes mellitus is a group of metabolic 
disorder characterized by chronic hyperglycemia and 
has a significant impact on the health and quality of life 
in patients [8]. In the present study, we investigated 
the effect of phenytoin on mRNA levels of Glut4 
(Glucose Transporter 4), Akt1 (protein kinase B), 
Leptin and Adiponectin (Adipoq) genes in the liver 
tissue of mouse treated with phenytoin as a models. 
Insulin is a key factor for managing blood glucose 
levels by facilitating cellular glucose uptake in several 
important tissues such as skeletal muscle, liver, and 
adipose tissue, by activating the PI3K-Akt signaling 
pathway [9].  
GLUT-4 is a protein that plays a crucial role in 
metabolism of carbohydrates [10]. Glucose uptake in 
peripheral tissues is mediated by insulin-dependent 
GLUT4. Insulin stimulate the PI3K-Akt signaling 
pathway and the activated Akt kinase subsequently 
catalyzes the phosphorylation of Akt1 substrate 160 
kDa (AS160), responsible for GLUT4 translocation to 
the plasma membrane and allows glucose uptake to 
the cells [11]. Akt1 was involved in this study because of 
its common role in signaling pathways that mediate 
the metabolic effects of insulin in numerous 
physiologically important target tissues [12]. Also, one 
of the most important of hormones in regulation of 
lipid and glucose level of body is leptin that encoded by 
LEP gene. Leptin that previously known as obesity 
factor, is an adipocyte-derived hormone that plays an 
important role in the regulation of energy stores and 
food intake [13]. Adiponectin/leptin ratio has been 
considered as a biomarker for detection of adipose 
tissue disorders. Leptin is an index of fat mass, and 
adiponectin is an index for triglyceride metabolism 
and insulin sensitivity. The people with high 
adiponectin/leptin ratios have better triglyceride 
profile [14]. Leptin may have some effects on specific 
peripheral targets including liver, and pancreas, 
adipocytes and skeletal muscle cells. Leptin improves 
hepatic insulin resistance and hyperglycemia through 
decreasing gluconeogenesis, increases fatty acid 
oxidation. On the other word, leptin deficiency can 
lead to insulin resistance diabetes [15]. Leptin can 
suppresses lipogenesis and glucose output in liver [16]. 
Adiponectin is another hormone produced by the 
adipocytes and encoded by Adipoq gene. This gene is 
down-regulated in obese diabetic patients. 
Adiponectin enhances insulin secretion to inhibit 
hepatic glucose production by reducing the 
gluconeogenic gene expression, so it induces glucose 
uptake and promotes fatty acid beta oxidation [17]. An 
optimal level between Leptin and Adiponectin is 
critical for maintenance of normal metabolism. In 
leptin-deficient (ob/ob) mice, maintaining 
adiponectin at lean levels, as opposed to the widely 
observed drop of adiponectin in the obese state, 
increases fat mass, yet improves insulin sensitivity [18, 
19]. Given to the role of AKt1, Adipoq, LEP and Glut4 
genes in regulation of glucose and lipid level of the 
blood, we think, phenytoin may influence the 
expression of these genes in the liver. Main goal of this 
study, was quantitation of the change in expression of 
these genes after a median term treatment with 
phenytoin in mouse as an animal model.   
 
2. Material and Methods 
2.1. Animals and drug treatment 
Experiments were performed on adult male 
BALB/c mice weighing 24±3 g. The animals were 
maintained under controlled room temperature (25 ± 
2°C) and light and dark (12:12 hr) conditions and were 
given standard food pellets and water. Before 
conducting the experiment, ethical clearance was 
obtained from the local Ethical committee on Animal 
Research and ethical guidelines for investigations were 
followed in accordance with Shahrekord University 
guidelines. Experiments consisted of two groups of 
animals, seven in each group. Group I (standard 
control), Group II (test drug, intraperitoneal injection, 
Phenytoin 15-20 mg/kg). Before injection, phenytoin 
was dissolved in distilled water and optimum 
concentration was calculated. The dose of the drug was 
calculated according to the manufacturer's 
recommendation per kg of body weight for a 25 g 
mouse. However, a conversion between mouse and 
human was carried out [20]. 
 
2.2. Liver tissue biopsy, RNA extraction and 
cDNA synthesis  
Mice were anesthetized by intraperitoneal 
injection (IP) injection of pentobarbital (0.7%, w/v) 
and culled by exsanguination. Livers were 
immediately excised under sterile conditions and 
directly subjected for total RNA extraction procedures 
using RNXplus buffer (Cinnagen Co., Iran) as 
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recommended by company manual. In the next step, 
cDNA synthesis was performed on about 50ng RNA 
by using the first strand cDNA synthesis kit (Add Bio 
Co., South Korea) using oligo (dT) and random 
hexamer primers according to the manufacturer’s 
instructions.  
 
2.3. Primer design and real-time RT-PCR assay 
Specific primers were designed using Gene runner 
version 6.5.52, 64-bit beta software against AKt1, 
Adipoq, LEP and Glut4 genes that listed in Table 1. 
Also a pair primers was designed for ActB gene as 
internal control or reference gene in relative gene 
expression analysis in real-time RT-PCR assay. The 
real-time RT-PCR assay was performed by using the 
One-step SYBR Green real-time RT-PCR (Takara Bio 
Inc., Japan). Each 20μL reaction mixture contained 10 
μL of 2X Master Mix, 0.5 μL of the 20 U/μL RNase 
inhibitor, 0.8 μL each of 10 μM forward and reverse 
primers and 1 μL of template cDNA. Amplification was 
carried out in 48-well plates on a real-time one-step 
RT-PCR machine (Applied Biosystems Co., USA). 
Thermal cycling conditions consisted of 10 min at 95°C 
and 45 cycles of 15 s at 95°C and 1 min at 60°C. Melting 
curve was calculated between 65°C and 95°C with 
0.3°C ramping rate. 
 
2.4. Gene expression and statistical analyses 
Expression changes of studied genes was 
calculated based on 2-ΔΔCt method [21]. All results are 
given as the mean ± SEM. Kolmograph-Smirnov 
method was used for normality assay of given data by 
SPSS version 26. Probabilities of chance differences 
between two groups were calculated using GraphPad 




As described in material and method, total RNA 
was extracted by using RNXplus solution and qualified 
in gel electrophoresis (Figure 1). The extracted RNA of 
28s and 18s rRNA shows an optimal quality.  
Supplementary file 1 shows the melt curves for 
target genes amplicons. The single peak is typically 
interpreted as representing a pure, single amplicon. 
Also, amplification plot for every genes is showed.   
As mentioned in this study, the expression 
changes of AdipoQ, Glut4, Leptin and Akt1 genes as 
candidate genes involved in the metabolism of lipids 
and carbohydrates under the administration of 
phenytoin were measured in liver by the 2-∆ΔCt method 
[18]. The statistical independent t-test method was 
carried out and the research hypothesis was tested and 
the results were presented. The distribution of data for 
Table 1. Primer sequences for used genes 
 
Primer name  Sequence Target length Target gene Accession no. 
mActF 5’- GGACTCCTATGTGGGTGACG-3’ 
119bp ActB NM_007393.5 
mActR 5’- AGGTGTGGTGCCAGATCTTC-3’ 
FAQ1 5’-ACTTGTGCAGGTTGGATGG-3’ 
139bp ADIPOQ NM_009605.5 
RAQ1 5’-CTGTCTCACCCTTAGGACC-3’ 
FLEP 5’-CACACACGCAGTCGGTATCC-3’ 
133bp Leptin FJ374142.1 
RLEP 5’-CAGGTCCTCACCAGCCTGCC-3’ 
FGL4 5`- AATGTCTTGGCCGTGTTGGG -3` 
118bp GLUT4 NM_009204.2 
RGL4 5`- GCCCTGATGTTAGCCCTGAG -3` 
FAkt1 5’-GCCTGAGGAGCGGGAAGAATG-3’ 
122bp Akt1 NM_001331107 
RAkt1 5’-CTTCAGCCCCTGAGTTGTCAC-3’ 
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the results of gene expression changes between control 
group and the animals treated with phenytoin was 
performed by Kolmograph Smirnov test. Kolmograph 
Smirnov test showed a significant equal with 0.2 that 
present normality of data distribution. Based on the 
result of Kolmograph Smirnov test, independent t-test 
was considered as significant test for analysis of gene 
expression change.  Figure 2 (A-D) show the result of 
GLUT4, Leptin, ADIPOQ and Akt1 genes expression 
analysis. 
4. Discussion 
In this study, we investigated the effect of 
phenytoin drug on the expression of four key genes in 
metabolism balance of lipids and carbohydrates. 
Several studies indicated that phenytoin can promote 
hyperglycemia in human and animal [6, 22, 23]. In a 
study in the rats, phenytoin significantly increased 
fasting plasma glucose, insulin resistance index, total 
cholesterol and triglycerides compared with the 
control group [6]. This phenomena is very important 
in about diabetic patients and the peoples that affected 
by obesity. We proposed here that this effects may 
resulted from an interference between the phenytoin 
drug and gene expression profile in liver. As a simple 
view, adiponectin has been shown to enhance insulin 
sensitivity in several reports that result in entrance of 
glucose into the adipocytes and liver cells. In this 
situation, Leptin hormone acts in reverse direction in 
releasing of glucose into the blood stream [18]. In our 
study, Adipoq gene expression showed 15 times 
increase (P <0.001) compared to the control group. 
Adiponectin level elevates with hyperglycemia 
independent of body size. Optimization of blood 
glucose in the hyperglycemic patients that tolerate 
decrease in adiponectin levels is independent of 
diabetes type and/or body weight [24]. Adiponectin 
played a critical role in regulating plasma glucose and 
reducing pancreatic islet apoptosis after gastric bypass 
surgery [25]. So, increasing of adiponectin that we 
reported in this study, may be a secondary or 
compensation result of hyperglycemia. In this 
situation, the body may changes its metabolic source 
from glucose consumption to lipid catabolism.  
Other result of our study, decreasing of GLUT4 
gene expression to 0.4 times (P <0.001) compare to 
control group, is compatible with this hypothesis. Also, 
in this study, we investigated the expression change of 
Adiponectin and Leptin genes under the phenytoin 
diet. Adiponectin/Leptin balance is one of the most 
important indexes for an optimal metabolic condition 
in the body [26]. Results of this study showed 
decreasing of Leptin to 0.76 (P <0.05) compare to 
control group. This decreasing of leptin level after the 
phenytoin consumption, may be a result of glucose 
level elevation in blood that can induce a satiety 
situation result in decrease of leptin production.  
Similar to our findings, some studies indicated 
that carbamazepine cause diminish in level of leptin in 
the patients’ blood [27]. Carbamazepine and 
phenytoin are two common anti-epileptic drug. 
Decreasing of GLUT4 gene expression that we 
reported here, must be considered beside of leptin 
diminish. Low level of leptin in blood can lead to 
decreasing of insulin secretion and decreased GLUT4 
gene expression. Previous researches showed that 
changes in GLUT4 gene expression under the high 
 
 
Figure 1. Separation and analysis of RNA. Green viewer-stained 1% TBE agarose gel showing RNA extracted 
from liver tissue of treatment (a: 1-7) and control group (b: 1-7) of mice. M: 100bp DNA size marker. 
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level of cAMP is accompanied by similar alterations in 
GLUT4 protein expression and glucose uptake, 
suggesting a role of GLUT4 gene expression in 
regulation of cellular insulin role in glucose transport 
[28]. Based on this findings, we proposed that 
decreased leptin that resulted from phenytoin drug 
may be act through a cAMP manner. As supportive 
reports, correlation analysis indicated that the 
decrease in GLUT4 gene levels was only observed in 
hyperglycemic mice. On the other hand, the glucose 
catabolic related genes do not exhibit any clear 
coordinate expression. Agitated expression of glucose 
catabolic genes may contribute to hyperglycemia and 
muscle insulin resistance [29]. Interestingly, a study 
showed that hyperglycemia correlate with increasing 
of GLUT1 protein, while, GLUT4 gene level is 
decreased under hyperglycemic condition [30]. It 
seems, because of a wide role of leptin hormone 
compared with restricted action of adiponectin, the 
expression changes in leptin gene shows lower 
variance.  
Finally we analyzed the expression of Akt1 gene 
after treatment of animals with phenytoin drug. Our 
result showed a more than 3 times increasing in 
expression for Akt1 gene compare to control group of 
mice (P <0.001). Akt1 is expressed in many 
mammalian tissues. Specially, during adipocyte 
differentiation in vitro, Akt1 is expressed at a relatively 
high level in the early stages of adipogenesis, however 
its expression is gradually decreased at later stages. 
Thus, it is possible that Akt1 is necessary for the early 
stages of adipogenesis [31]. Also. Akt1 has a well-
 
 
Figure 3. Gene expression changes between control and Phenytoin treated groups. a: GLUT4 gene showed 0.456 decrease in 
expression compared to the control group (P ≤0.001, Sig.= 0.00). b. Leptin gene expression, which decreased by about 0.76 (P ≤0.05, 
Sig. = 0.01, Fold change = 0.76152) compared to the control group. c: Changes in the expression of Adipoq gene, which is an increase 
of about 15 times (P ≤0.001, Sig. = 0.00, FC = 14.78263) compared to the control group.  d: Akt1 gene expression with increase of 
more than 3 times (P ≤0.001, Sig. = 0.00, FC = 3.25971) compared to the control group. 
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defined role in phosphorylation and translocation of 
GLUT4 protein [32, 33]. This role can explains 
increasing of Akt1 gene expression under phenytoin 
consumption while GLUT4 gene level has decreased. 
On the other word, we think that, Akt1 gene expression 
is increased to compensate the low level of GLUT4 
protein. Considering the finding of this study, it can be 
concluded that phenytoin is a relatively high-risk 
antiepileptic drug for obesity and metabolic syndrome, 
but more studies are needed. 
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